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Abstract
Background: Pill testing services could potentially be used to reduce drug-related harm. This study aims to identify
patterns of ecstasy use among live music event attendees; explore the opinions and potential usage of illicit pill
testing programs and examine factors associated with the likelihood of still taking a pill containing a potential
harmful substance.
Methods: A cross-sectional survey was completed by 760 people attending a major Australian live music event in 2017.
Results: The most commonly used drug in the last 12months was ecstasy (73.9%). About 5% of people who use drugs
had sought medical attention due to consumption of ecstasy. People who use drugs agreed “a lot” that pill testing
should be provided for free at live music events (82.2%) and that it should be combined with harm reduction advice
(62.9%). Additionally, 32% of all participants agreed ‘a lot’ that they would be more likely to take illicit drugs at a music
festival if pill-testing services were present. However, if people perceived that a harmful substance was detected in their
drugs after using a pill testing service, 52.3% of people who have used illicit drugs reported that they would ‘not at all’ be
likely to still consume the drug. They also reported that they would still take a pill if testing demonstrated the presence of
unintended MDMA-type substances (70.3%), amphetamines (31.2%) or ketamine (27.8%). Multivariate analyses
demonstrated that only increased frequency of ecstasy use was significantly associated with taking a pill despite pill
testing services detecting a harmful substance. Gender, age, alcohol and previously seeking ecstasy-related medical
attention were not associated in the multivariate analyses.
Conclusions: A high proportion of live music attendees consume alcohol and ecstasy. Both people who have and who
have not used illicit drugs support the implementation of pill testing services. People reported they would change their
consumption patterns according to the results given by pill testing services. The findings may be used to stimulate public
debate, and assist drug and alcohol policy makers in the implementation of harm minimisation strategies such as
combining pill testing services with harm reduction advice.
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Background
Ecstasy use and its associated risk profile has become in-
creasingly relevant in western society, with Australia
ranking as the highest per capita consumer of the drug
in the world as per the 2014 United Nations World
Drug Report [1]. A survey conducted by the Ecstasy and
Related Drugs Reporting System (EDRS) in 2017 re-
vealed it to be the most popular illicit drug for 36% of
respondents who had used psychostimulants in the last
6 months [2]. Trends in the place of consumption indi-
cate that the majority of ecstasy use occurs at public en-
tertainment events and venues, with live music events
being the 2nd most frequent location for ecstasy con-
sumption in Australia [2]. From a wider sample of the
Australian population 14 years and over, 400,000 people
(2.2%) had used ecstasy in the last 12 months, whilst
general illicit drug use in the same time period was re-
ported amongst 15.6% of respondents [3]. The use of
such illicit drugs remains highest in the 20–29 age cat-
egory (32%) [3], with the median age of ecstasy use being
28 years [3]. Illicit drug use costs the Australian econ-
omy $8 billion annually; this includes losses in product-
ivity, health care costs and those associated with
combatting trafficking and production [4].
Ecstasy is a prohibited substance as per The Drug Mis-
use and Trafficking Act 1985 [5]. Consequent to the
drug primarily being sourced through illegal avenues,
there exists a lack of regulation and quality assurance as-
sociated with its production, creating significant risk to
consumers who are often exposed to adverse side effects
from added substances and impurities. As of 2016, al-
most 9.3% of the participants surveyed who had taken
drugs had been the victim of an ‘illicit drug related inci-
dent’, which ranged from a mild reaction to serious ad-
verse health outcomes; injury or death [3].
Many studies internationally, such as Israel [6] and the
UK [7, 8], have explored the morbidity and mortality as-
sociated with ecstasy, including headaches, dehydration,
agitation, hypertension, hyperthermia, loss of conscious-
ness, cerebral oedema, serotonin syndrome, multi-organ
failure and in some instances, sudden death [6–8]. Over-
doses involving ecstasy pills and the added substances
they contain have also been reported amongst users,
with 58% of stimulant related overdose respondents at-
tributing their overdose to the consumption of ecstasy in
2016–2017 [2].
Drug markets are not stable and vary per country. A
2006 U.S. study found that, based on testing the content
of ecstasy, a large proportion of ecstasy sourced from
users (46%) did not contain any of its active ingredient;
3,4-Methylenedioxymethamphetamine (MDMA), and
15% of those tested contained a mixture of MDMA and
other miscellaneous substances. The most common con-
taminant being Methylenedioxyamphetamine (MDA),
methamphetamine, caffeine, dextromethorphan (DXM)
and pseudo-ephedrine [9]. There were other substances
detected including ketamine, dimethoxyamphetamine
and heroin, albeit in a small percentages [9]. A 2012
Dutch study found that the occurrence of adverse events
associated with ecstasy use, such as palpitations, agita-
tion, hyperthermia and seizures could be attributed to
the presence of contaminants such as MDA and meta-
chlorophenylpiperazine (mCPP) [10]. Australia Drug
Trends 2017 [2] also found increased availability of more
potent forms of ecstasy when compared to previous
years, raising concerns of increased potential harm for
users.
These underlying dangers mean some organisations
advocate for pill testing. For example, the Australian
Drug Law Reform Foundation of Australia, have lobbied
for legislative changes that allow pill testing services at
Australian live music events as a means of harm mini-
misation [11]. The principle of harm minimisation
formed the basis of the Australian National Drug Strat-
egy since 1985. The harm minimisation framework en-
compasses three pillars: supply reduction, demand
reduction and harm reduction, [12]. Pill testing falls
under the principle of harm reduction, which Harm Re-
duction International defines as ‘policies, programs and
practices that aim to reduce the harms associated with
the use of psychoactive drugs in people unable or unwill-
ing to stop’ [13].
Internationally, many countries throughout Europe
have existing pill testing facilities or ‘drug checking ser-
vices’ which have been legislated for and instituted at
festivals over the last 25 years as a harm minimisation
strategy [14–16]. Success has been seen in various areas
from implementation of this harm reduction strategy, in-
cluding rapid on-site identification of contaminants and
purity, identification of contaminated pill presses or
batches [14], facilitation of contact between health ser-
vices and ecstasy users [15], as well as serving as the
basis for effective public warning systems in generating
awareness of circulating harmful batches [15, 16].
Regularly, there is media attention surrounding pill
testing at live music events which is presented by re-
porters and include the views of predominantly authority
groups and political leaders on the topic [17, 18]. The
at-risk population likely to utilise pill testing services ap-
pear to be underrepresented, and underreported. Few
studies have examined pill testing in the context of Aus-
tralian ecstasy and illicit drug usage, although the evi-
dence is increasing. Previous papers have analysed the
accuracy of pill testing, as seen in an Australian study
conducted in 2005 by Camilleri & Caldicott [19]. More
recently, a few Australian studies have assessed public
opinion on pill testing. An online survey conducted in
2013 by the National Drug and Alcohol Research Centre
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[20] revealed 82.5% of respondents supported the imple-
mentation of a pill testing service. However, a much
higher proportion of people in this survey had used ec-
stasy, with 47.7% asserting they had consumed ecstasy
[20] versus the 8% found in National surveys across
Australia [3]. Although the results represented the opin-
ions of the Australian youth on this issue, the study only
ascertained whether the individuals were in support of
or against pill testing. There is a need to explore the role
and expectations of pill testing services and their value
in harm reduction at Australian live music events. A
2016 study investigated the perceptions of music festival
attendees in detail and showed similar support for pill
testing services with 86.5% of participants believing that
pill testing services could help reduce harm [21]. Similar
results were found by another recent study conducted
by Barratt et al., whereby it was found that 94% would
utilise a pill testing service at a festival [22]. This study
builds further on the 2016 work conducted by Day et al.
[21]. Since the 2016 survey [21], there have been a num-
ber of high profile deaths in Australia at live music
events from drug overdose [23], which may have poten-
tially influenced the opinions of live music festival at-
tendees. Additionally, this study will focus on the
opinions of ecstasy users in particular.
This paper aims to:
1. Identify characteristics and patterns of Ecstasy/
MDMA use among live music event attendees
2. Explore the opinions of live music event attendees
on pill testing programs
3. Identify the proportion of people that have used
illicit drugs that would still take a pill after results
of pill testing show the presence of unintended
drugs or substances
4. Examine among people who have used illicit drugs
which factors are associated with the likelihood of
still taking a pill despite a pill testing service
detecting a harmful substance in the pill.
Methods
Study design
A cross-sectional survey was conducted.
Setting, participants and recruitment
Eligible participants were those aged over 18 attending a
three-day large mixed-genre live music event in New
South Wales in 2017. Surveys were distributed by five
members of the research team throughout the course of
the festival between 9 am and 12 pm each day. The five
members were in their early twenties and consisted of
two females and three males. The rationale for surveying
between these times was to avoid intoxicated attendees
later in the day. Potential participants were approached
face-to-face and invited to complete the paper-based
survey. Researchers were equipped with RSA (Respon-
sible Service of Alcohol) skills to recognise those who
may have been under the influence of alcohol and these
individuals were excluded from the survey. Participants
were given a Participant Information Statement and
were told what was involved and what the study aims
were. The survey was completed anonymously to ensure
confidentiality. No identifying information was collected
to ensure anonymity of participants. A self-completed
survey format was used rather than an interview format,
to minimise any discomfort regarding the sensitive na-
ture of the questions. Completion of the survey was
taken as consent.
Outcome measures
The survey was adapted from the 2016 survey by Day
et al. [21] The study by Day et al. was conducted at the
same festival the year prior to the current study and in-
cluded the same target population. Additionally, similar
recruitment methods were used for both surveys. The
2016 survey was completed by 625 people. The 2017
survey included additional questions based on current
literature and expert opinion (See Additional file 1). All
participants completed a core set of questions regarding
demographics, employment and study, sexual orienta-
tion, relationship status, alcohol consumption and Likert
scale questions where participants were able to choose
to what extent they agreed with certain statements about
pill testing and its potential effectiveness at live music
events. Alcohol consumption was assessed using ques-
tions from the World Health Organisation Alcohol Use
Disorders Identification Test: The AUDIT-C [24]. Atti-
tude questions towards pill testing were derived from a
previous study [21]. The attitude questions were pre-
ceded with the following statement: “Pill testing services
could test drugs by taking a small sample. A reagent test-
ing kit is used to test this sample, gathering information
on its contents. The user can then be informed of the
presence of potentially harmful ingredients/substances.”
An open-ended question was added asking whether pa-
trons had any concerns about pill testing at music
festivals.
The second section was only completed by people who
reported ever having taken illicit drugs. Questions re-
garding the use of illicit drugs were derived from the
National Drug Strategy Household Survey [3]. Questions
measured type of drug used in the last 12 months, de-
tailed questions about ecstasy use, how concerned they
were about their health in relation to content and/ or
purity of illicit drugs and if they would utilise pill testing
services. To identify how participants perceived that pill
testing services would influence their behaviour, partici-
pants were asked a general question: “If a harmful
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substance was detected in your drugs using the pill test-
ing service, how likely would you be to still consume
them?” with answers ranging between ‘not at all’, ‘a lit-
tle’, ‘somewhat’ and ‘a lot’. Participants were also asked a
more specific question: “Would you still take a drug if
the results of a drug testing kit/ pill testing service indi-
cated the presence of the following unintended drugs?”.
The response options were: ‘yes’, ‘no’ or ‘don’t know’.
(See Additional file 1 for full list of drugs). Open-ended
questions asked about other substances individuals had
consumed at the same time as ecstasy and the amount
they would be willing to pay for the service if it were not
free. Two pilot testing sessions were conducted during
survey development to test the data collection tool on
groups of young adults (n = 15 and n = 10). The 1st
pilot-tests was conducted among students and young
people directly known to the researchers. This group
was chosen because the music festival is attended mainly
by young people, and thus represented the target popu-
lation. The second pilot test was conducted among uni-
versity students.
Statistical methods
Chi-square tests were used to determine whether alcohol
use was associated with the likelihood of altering drug
taking behaviours based on pill testing results as well as
for determining the association between those that had
used illicit drugs or not with attitudes towards pill test-
ing. P-values less than 0.05 were considered to indicate
statistical significance.
Among MDMA users, the question “If a harmful sub-
stance was detected in your drugs using the pill testing
service, how likely would you be to still consume them?”
was categorised into: “not at all” versus “would con-
sider”. The “would consider” group included those that
had answered “a little”, “somewhat” or “a lot”. Logistic
regression was used to calculate crude and adjusted odds
ratios to identify which factors were significantly associ-
ated with MDMA users consuming a pill even if a harm-
ful substance was detected in their drugs after using a
pill testing service. SPSS Version 22 was used.
Results
Socio-demographics and drug use characteristics and
patterns
The survey was completed by 760 people between the
ages of 18 and 56 and took approximately 5 min to
complete.
Sample description
The majority of participants were male (55%), aged 18–
21 (59.6%), single (50.8%), heterosexual (91.3%),
employed (92.6%) and/or fulltime students (40.6%)
(Table 1). Of all participants, 40.9% reported using
alcohol 2–3 times per week. Most participants reported
having used illicit drugs (83.9%) in their lifetime and the
most commonly used drugs in the last 12 months were
ecstasy/MDMA (73.9%), cannabis (64.3%) and cocaine
(45.5%) (Table 2). Some people who have used illicit
drugs reported having time off work due to illicit drug
use (16.7%) and just over one in four reported that they
had gone to work or study despite feeling that they
should have taken sick leave due to their use of illicit
drugs (Table 2).
Comparison with 2016 sample
The 2017 sample differed when compared to the
Day et al. 2016 study sample [21]. In 2016, 39% were
Table 1 Participant characteristics (N = 760)
2017% Comparison data 2016a%









Relationship status (n = 756)
Married/ de facto 4.8 1.6
Single 50.8 56.8
In a relationship 43.2 41.0
Separated/divorced/widowed 0.8 0.6





Employment status (n = 757)b
Full time student 40.6 48.9










aSource: Day et al., 2018 [21]; b Multiple responses possible
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men [21], however in the 2017 sample there was a
higher proportion of males to females. Relationship
status was similar in both groups as was the spread
of sexuality. Unemployment rates were higher in
2016 (12.5%) [21] compared to 2017 (1.6%). Table 2
compares drug use in 2017 compared to what was
found in 2016. Reported drug use in the 2017
sample was higher for every substance than in 2016.
This was especially evident for ecstasy/MDMA with
73.9% in 2017 compared with 59.8% in 2016 [21], as
well as cocaine use, 45.5% in 2017 compared to
34.1% in 2016 [21]. Use of methamphetamines and
inhalants in 2017 was just over double what it was
in 2016 [21].
Table 2 Prevalence drug and alcohol use among participants (N = 760)
Variable 2017% Comparison data 2016a%
ILLICIT DRUGS
Ever used illicit drugs (n = 758) 83.9 –














Taken time of work/ study in the last 12months due to illicit drug use (n = 617) 16.7
Gone to work/ study despite feeling they should have taken sick leave due to illicit drugs use (n = 610) 27.5
ALCOHOL
Frequency of alcoholic drink (n = 758)
Never 0.1 –
Monthly or less 8.2 –
2–3 times per month 38.5 –
2–3 times per week 40.9 –
More than 4 times per week 12.3 –
Standard drinks per drinking session (n = 753)
1 to 2 10.0 –
3 to 4 12.4 –
5 to 6 22.2 –
7 to 9 23.6 –
More than 10 31.9 –
Frequency > 6 standard drinks on one occasion (n = 754)
Never 0.4 –
Less than monthly 13.5 –
Monthly 39.1 –
Weekly 45.1 –
Daily or almost daily 1.9 –
aSource: Day et al., 2018 [21]
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Among those who reported having used illicit drugs in
the past (n = 636), a high proportion (87.8%) reported
having consumed MDMA/ecstasy at a live music event
(Table 3). Of this sample of MDMA/ecstasy users at fes-
tivals (n = 548) the majority (82%) reported mixing
MDMA/ecstasy with other substances. The most com-
mon substances that were mixed with MDMA/ecstasy
included alcohol (46.8%), cannabis (31.2%) and cocaine
(24.5%). The majority of MDMA/ecstasy users reported
using monthly (32.1%) or every 6 months (30.9%) and
4.6% reported having to seek medical attention.
Opinions of live music event attendees on pill testing
programs
Table 4 demonstrates all participants’ attitudes towards
pill testing services. The majority of participants agreed
Table 3 Characteristics of MDMA/ Ecstasy use in 2017 at live music events among participants who have ever used illicit drugs (N =
636)
Percent
Ever used MDMA/ ecstasy at a life music event (n = 636)
Ever consumed MDMA/ecstasy at a live music event 87.8
Ever mixed MDMA with other substances at a life music event 82.0




















Frequency of MDMA/ecstasy use (n = 548)
Fortnightly or more 12.9
Monthly 32.1
6 monthly 30.9
Yearly or less 16.0
Never 8.1
Medical attention sought due to MDMA/ecstasy (n = 548) 4.6
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‘a lot’ (79.2%) or ‘somewhat’ (15.5%) that pill testing ser-
vices should be provided for free at live music events.
Conversely, the majority disagreed with providing pill
testing services at a cost responding with ‘not at all’
(38.9%) or ‘a little’ (22.8%). Most agreed ‘a lot’ (75.2%)
and ‘somewhat’ (19.1%) that pill testing services could
help people that use drugs to seek help and reduce harm
and similarly ‘a lot’ (62.5%) and ‘somewhat’ (25.9%)
agreed that pill testing services should be combined with
harm reduction advice.
Compared to people who do not use illicit drugs,
people who use drugs were found to be significantly
more likely to support pill testing being provided for free
at live music events, more likely to believe that pill test-
ing services could help people who use drugs to seek
help and reduce harm, and were significantly more likely
to take illicit drugs at live music events if pill testing was
provided.
Comparison with 2016 sample
There was a small difference in the responses to whether
pill testing should be provided for free at live music
events with a higher response for those agreeing “some-
what” or “a lot” in our survey (94.7%) compared to the












Comparison data 2016a Percent
Pill testing should be provided for free at live music events (n = 756)c,d
Not at all 2.9 3.0 2.5 χ = 25.72,df = 3, p < 0.001 Not at all/ a little 11.8
A little 2.4 1.7 5.7
Somewhat 15.5 13.1 27.9 Somewhat/ a lot 86.2
A lot 79.2 82.2 63.9
Pill testing should be provided at a cost at live music events (n = 754) c,d,e
Not at all 38.9 37.8 44.6 χ = 4.0, df = 3, p = 0.26 Not at all/ a little 32.5
A little 22.8 22.6 24.0
Somewhat 25.1 26.4 18.2 Somewhat/ a lot 67.5
A lot 13.3 13.3 13.2
Pill testing services could help drug users seek help to reduce harmd (n = 743)
Not at all 2.4 2.2 3.3 χ = 18.20,df = 3, p < 0.001 Not at all/ a little 13.5
A little 3.2 2.7 5.8
Somewhat 19.1 16.9 30.8 Somewhat/ a lot 86.5
A lot 75.2 78.2 60.0
Pill testing services should be combined with harm reduction advice (n = 753) d
Not at all 3.2 3.2 3.3 χ = 0.22,df = 3, p = 0.975 Not at all/ a little 15.1
A little 8.4 8.4 8.3
Somewhat 25.9 25.6 27.5 Somewhat/ a lot 84.9
A lot 62.5 62.9 60.8
Drug sellers may use the service as a quality control mechanism (n = 751)
Not at all 10.5 10.2 12.4 χ = 4.73,df = 3, p < 0.192 Not at all/ a little 31.4
A little 16.6 15.9 20.7
Somewhat 30.4 29.8 33.1 Somewhat/ a lot 68.6
A lot 42.5 44.1 33.9
I would be more likely to take illicit drugs at a music festival if pill testing services were present (n = 750)
Not at all 25.3 23.5 35.3 χ = 15.46,df = 3, p = 0.001 –
A little 18.0 17.4 21.0
Somewhat 24.7 24.4 26.1
A lot 32.0 34.7 17.6
a Source: Day et al, 2018 [21]; b df degrees of freedom; cIn 2016, the word ‘festivals’ was used instead of ‘live music event’; d In 2016, the words ‘drug checking
services’ was used instead of ‘pill testing services’; e In 2016, the question was worded as follows: “If not free, drug checking services should be provided AT-COST
at festivals”
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2016 survey (86.2%) [21]. There was a larger difference
in the responses to whether pill testing should be pro-
vided at a cost at live music events with a lower response
for those agreeing “somewhat” or “a lot” in our survey
(38.4%) compared to the 2016 survey (67.5%) [21]. Com-
pared to 2016, participants in 2017 reported slightly
higher levels of agreeing ‘somewhat’ or ‘a lot’ with the
statement ‘Pill testing services could help drug users
seek help to reduce harm’ (94.3% in 2017 versus 86.5%
in 2016). Similar proportions in 2017 (88.4%) and 2016
(84.9%) of participants agreed ‘somewhat’ or ‘a lot’ that
‘Pill testing services should be combined with harm re-
duction advice’. Finally, similar proportions in 2017
(72.9%) and 2016 (68.6%) agreed ‘somewhat’ or ‘a lot’
that drug sellers may use the service as a quality control
mechanism.
Participants who had previously used illicit drugs (n =
636) were asked about their opinions on their pills
(Table 5). Most participants agreed ‘somewhat’ (38.3%)
or ‘a lot’ (20.9%) that they were concerned about the
content and/or purity of their illicit drugs in terms of
their health. When asked if they were likely to consume
their drugs if a pill testing service found they contained
a harmful substance, a large proportion of respondents
were unlikely to, with responses of ‘not at all’ (52.3%)
and ‘a little’ (25.9%) being the most prevalent. Responses
were mixed in regards to how likely participants cur-
rently are to test the content and/or purity of their illicit
drugs. A high proportion of participants agreed ‘some-
what’ (17.1%) or ‘a lot’ (73.3%) that they were likely to
use a free pill testing service if it was provided at live
music events.
Comparison with 2016 sample
When compared to 2016 survey data, there was a slight
increase in individuals who reported being ‘somewhat or
‘a lot’ concerned in terms of their health about the content
and/or purity of illicit drugs taken from 52.8% in 2016
[21] to 59.2% in 2017. In 2016, 13% responded that they
would not at all be likely to utilise a free pill testing service
[21] compared to only 3.1% of individuals in 2017. The
majority of individuals in 2016 and 2017 responded that
their likelihood of using a pill testing service was ‘a lot’
however this was higher in the 2017 cohort (73.3%) com-
pared to 2016 data where 54.4% responded it was ‘highly
likely’ they would use a free drug checking service [21].
Considerations of still taking a drug if the results of a
drug testing kit/ pill testing service indicated the
presence of unintended drugs
Table 6 shows whether pill testing would influence drug
consumption among people who use drugs, if it showed
that the pill had various unintended drugs. A majority of
participants indicated they would still take the drug if it
contained MDMA-type substances (70.3%), this was
followed by amphetamine (31.2%), ketamine (27.8%),
opiates (17.8%), and methamphetamine (17%). The 2017
findings were very similar to the 2016 data, however
there was an increase from 20.9% in 2016 [21] to 27.8%
in 2017 of those who would still take a pill if it uninten-
tionally contained ketamine.
Factors associated with the likelihood of still taking a pill
despite a pill testing service detecting a harmful
substance in the pill
Table 7 demonstrates that the more frequently people
drink, the more likely they are to consider taking a pill
even if a harmful substance was detected in their drugs
after using a pill testing service. Similarly, the more fre-
quently people would consume more than six standard
drinks in one session, the more likely they are to con-
sider taking a pill even if a harmful substance was de-
tected in their drugs after using a pill testing service.
Table 8 demonstrates that those who drink alcohol
more than four times a week are more likely to consume
a pill even if a harmful substance was detected in their
Table 5 Behaviour among people that ever used illicit drugs
(N = 636)
% (n) Comparison data 2016a Percent
In terms of your health how concerned are you about the content
and/or purity of the illicit drugs you take (n = 618)
Not at all 13.8 Not at all/ a little 47.2
A little 27.0
Somewhat 38.3 Somewhat/ a lot 52.8
A lot 20.9
If a harmful substance was detected in your drugs using the pill
testing service, how likely would you be to still consume them?
(n = 618)




Currently, how likely are you to attempt to find out about content
and/or purity of the illicit drugs you intend to take? (n = 615)




How likely is it that you would use a free pill testing service? (n =
615)




a Source: Day et al, 2018 [21]
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drugs after using a pill testing service (crude OR 1.935,
95%CI 1.116–3.357). Similarly, those using MDMA daily,
weekly or fortnightly were more likely to consume a pill
even if a harmful substance was detected in their drugs
after using a pill testing service when compared to six
monthly, yearly or one time users (crude OR 2.124,
95%CI 1.457–3.097). However, multivariate analyses
demonstrated that only increased frequency of MDMA
use was significantly associated with taking a drug des-
pite pill testing services detecting a harmful substance
after adjusting for all other variables.
Discussion
Multivariate analyses demonstrated that only frequency of
ecstasy use was significantly associated with taking a pill
despite pill testing services detecting a harmful substance.
Gender, age, alcohol and previously seeking ecstasy-related
medical attention were not associated in the multivariate
analyses with taking a pill containing harmful substance.
In univariate analyses, a correlation was found with
the frequency of high risk or “binge” drinking and its as-
sociation with the likelihood of still taking a pill despite
a pill testing service detecting a harmful substance.
Table 6 Proportion of people that have used illicit drugs that would still take a drug if the results of a drug testing kit/ pill testing










MDMA- type substances (MDA, MDE) (n = 622) 70.3 10.5 19.3 69.7
Amphetamine (n = 622) 31.2 36.8 32.0 32.9
Ketamine (n = 622) 27.8 42.1 30.1 20.9
Opiates (n = 622) 17.8 41.3 40.8 15.7
Methamphetamine (n = 622) 17.0 52.3 30.7 14.9
2C-B/C/I (n = 622) 6.4 43.1 50.5 7.9
DXM (n = 621) 6.0 44.4 49.6 7.0
No reaction (benign or unknown substances) (n = 622) 5.9 41.8 52.3 6.3
PMA/PMMA (n = 622) 3.9 44.2 51.9 3.8
Methylone (n = 622) 3.2 45.2 51.6 3.1
Butylone (n = 632) 3.1 45.2 51.8 1.8
DOB (n = 622) 2.9 44.1 53.1 3.1
Naphyrone (n = 622) 2.9 45.2 51.9 1.9
DOI (n = 622) 2.4 43.9 53.7 3.1
Other (n = 622) 2.1 42.3 55.6 2.5
1 Source: Day et al, 2018 [21]
Table 7 Alcohol and its association with the likelihood of still taking a pill despite a pill testing service detecting a harmful
substance in the pill among people who use drugs (N = 636)
Would not consider Would consider Chi-square, dfa, p-valueb
How often do you have a drink containing alcohol? (n = 618)
Never 0.0 100.0 χ = 13.30, df = 4, p = 0.006
Monthly or less 62.8 37.2
2–3 times per month 58.5 41.5
2–3 times per week 49.4 50.6
4+ times weekly 38.8 61.3
Frequency of 6+ standard drinks in 1 session (n = 613)
Never 0.0 100.0 χ = 12.03, df = 4, p = 0.010
Monthly or less 67.9 32.1
2–3 times per month 53.3 46.7
2–3 times per week 48.3 51.7
4+ times weekly 33.3 66.7
a df degrees of freedom b Exact values used due to small numbers
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There was a steady increase in the proportion of
people who would consider taking a pill, even if a harm-
ful substance was detected in their drugs after using a
pill testing service, in relation to their increasing fre-
quency of hazardous drinking. Hazardous alcohol con-
sumption, as well as the willingness to consume a pill
that may harm the individual, reflect risk-taking behav-
iours. It is unsurprising therefore that individuals who
partake in risk-taking, hazardous alcohol consumption
may also be inclined to demonstrate risk-taking behav-
iour associated with their pill taking habits. The link be-
tween ecstasy consumption and risk-taking behaviour is
well supported in the literature [25].
Analysis of trends in amount of ecstasy consumed by
people that use illicit drugs revealed that whilst the pro-
portion of people that had ever consumed ecstasy at a
live music event was high (87.8%), 20.8% took a rela-
tively low dosage of MDMA/ecstasy at any one time
(100 mg or less). However, 65.2% of ecstasy users con-
sumed between 101 and 500mg of MDMA/ecstasy in
one session and 14.1% consumed greater than 500 mg of
MDMA/ecstasy in the same time period. These results
reflect a group of people putting themselves at risk of
adverse effects, given that the results of a study con-
ducted in 2012 showed that detrimental reactions were
more likely to occur at MDMA dosages greater than
120 mg [10]. It is worthy to note that the accuracy in
reporting dosages ingested may be compromised by the
fact that the actual MDMA content may differ from
what is expected [9]. In keeping with the aforementioned
high risk-taking behaviour seen among young festival
goers, the frequency of ecstasy use was also relatively
high; with 12.9% reporting use every 2 weeks or more
and 32.1% reporting monthly use.
Our research reinforced many of the findings pub-
lished by Day et al. [21]. Overall, all drug use appears to
be higher in our sample than the 2016 sample. This may
have been due to chance. The main demographic differ-
ence between the two samples was the gender ratio.
There was also an increased reported unemployment
level in the 2016 sample. All other demographics were
comparable.
Another notable difference between the 2016 and
2017 studies was the increase in reported ecstasy use.
Day et al. found that 59.8% of respondents had used ec-
stasy in the preceding 12months [21], whereas in our
study, 73.9% reported using ecstasy in that time period.
This variation could potentially be explained by the dif-
ference in gender distribution between the two survey
samples, with a 55% male majority in our study com-
pared to a 61% female majority in the 2016 study [21],
thus resulting in a difference in reported ecstasy use.
Other confounding factors could be, for example, the
frequency of attending live music events by participants
but this was not measured in either study. The opinions
of pill testing services were generally similar between
2016 and 2017. The most notable difference was that a
lower proportion of 2017 participants agreed ‘somewhat’
or ‘a lot’ that pill testing should be provided at a cost at
live music events (38.4% in 2017 versus 67.5% in 2016).
This may be explained by the lower number of ecstasy
users in the 2016 sample [21].
Table 8 Crude and adjusted odds ratios and multivariate logistic regression among MDMA users that would consider taking a pill,
even if a harmful substance was detected compared to those who would not take the pill
% P value Crude
OR




Lower Upper Upper Lower
Gender
Male 59.1 0.146 1.292 0.915 1.825 .158 1.298 .904 1.864
Female 40.9 – 1.000 – – – 1.000 – –
Age per year (continuous) – 0.245 0.974 0.931 1.018 .153 .965 .919 1.013
How often do you have a drink containing alcohol?
Never/ monthly or less/ 2–3 times a month 42.3 – 1.000 – – .072 .578 .318 1.051
2–3 times a week 45.1 0.064 1.406 0.980 2.018 .206 .687 .383 1.230
4 or more times a week 12.6 0.019 1.935 1.116 3.357 1.000 – –
How often do you use MDMA?
Six month/ yearly/ once 49.6 – 1.000 – – – 1.000 – –
Monthly 35.7 0.002 2.280 1.364 3.809 .042 1.775 1.022 3.082
Daily/weekly/fortnightly 14.6 < 0.0005 2.124 1.457 3.097 .004 1.785 1.203 2.647
Have you ever had to seek medical attention due to taking MDMA?
Yes 4.8 0.049 2.349 1.003 5.498 .105 2.173 .850 5.555
No 95.2 – 1.000 – – – 1.000 – –
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The findings of our study were further supported by
Barrat et al. 2017 [22] who examined the acceptability of
design features of pill testing services. They found that
94% of participants in their survey would use a pill test-
ing service at music festivals or clubs. Whilst the ques-
tion posed by Barrat et al. differed in that they queried
whether participants would personally use the service
versus our question regarding whether participants be-
lieved pill testing should be made available in a live
music event setting, both showed a large majority in
favour of the implementation of pill testing [22].
Compared to the 2016 survey, our data also showed a
trend that indicates individuals are more concerned
about their wellbeing when consuming illicit substances
and increasingly likely to utilise pill testing services. In
our survey only 3.1% of individuals responded that they
would be ‘not at all’ likely utilise a free pill testing service
compared with 13% in 2016 [21]. Almost three quarters
of the individuals (73.3%) surveyed responded that their
likelihood of using a pill testing service was ‘a lot’; when
compared to 2016 data, where 54.4% of individuals
responded it was ‘highly likely’ they would use a free pill
testing service [21]. However, it should be acknowledged
that this could be due to chance and we used conveni-
ence sampling. Future research, could examine changes
in attitudes towards drug-checking over time and con-
trol for baseline differences.
Another important finding of our study is the extent
to which individuals would heed the results of pill test-
ing services if they were to be made available at Austra-
lian live music events. Over half of respondents (52.3%)
answered that if a harmful substance was detected they
would be ‘not at all’ likely to consume the drug. An add-
itional 25.9% responded they would be ‘a little’ bit likely
to consume the pill. This finding is poignant for policy
makers as it indicates that individuals would not only
utilise pill testing services, but would also trust and act
upon the outcome of such testing, therefore altering
consumption habits. However, still about half of the par-
ticipants said they would consider taking the drug.
When these findings are combined with increased indi-
vidual investigation into the content and/or purity of
their pills and the increased likelihood of utilising pill
testing services should they be available, it is evident that
people who use drugs are interested in participating in
harm minimisation programs. These would have the po-
tential to influence individual consumption patterns and
potentially prevent individuals suffering adverse health
outcomes. However, we also acknowledge that a variety
of preventive actions are required for specific circum-
stances and different population needs. We also acknow-
ledge that the risk of not detecting harmful substances
with pill-testing services, and their reliability and accur-
acy remains.
Pill-testing has often been at the forefront of political
debate in the last decade, particularly in terms of the in-
tersections between drug policy, law enforcement praxis
and perceptions of community safety. This context
needs to be recognised. Our paper may be able to add to
the debate about pill-testing, contributing valuable em-
pirical data to inform knowledge and policy reform,
whilst keeping the study limitations in mind. A concern
of many opponents of pill testing is whether the avail-
ability of such a service would increase the prevalence of
drug taking at live music events. We asked our partici-
pants how much they agreed with the statement “I
would be more likely to take illicit drugs at a music festi-
val if pill testing services were present”. We found that
about one in four (23.5%) people who use illicit drugs
and about one in three people who do not use drugs
(35.3%) said they would be ‘not at all’ more likely to con-
sume drugs at a festival if pill testing is available. Simi-
larly, 34.7% of people who use drug versus 17.6% of
those who do not use drug replied that they would be ‘a
lot’ more likely to. This indicates that a proportion of at-
tendees are more likely to consume drugs, if pill testing
services were made available to them, but this propor-
tion is smaller among those who do not take drugs. A
2011 Swiss study found that following the provision of
drug checking facilities in Zurich, there was no increase
in the frequency of consumption of most party drugs or
in polydrug use (https://harmreductionjournal.biomed-
central.com/articles/10.1186/1477-7517-8-16).
Limitations
Self-report and the inability to draw causal relationships
were limitations. Due to the nature of the survey, people
participating in illegal activities, such as the consump-
tion of illicit substances, may have been reluctant to par-
ticipate due to fears of police or festival security
involvement, and prosecution for divulging this informa-
tion. This means those partaking in illicit activities may
be underrepresented in the data results of this study and
represent non-responder bias. To combat this, the sur-
vey was specifically made anonymous so it was not pos-
sible to link the survey back to people who had
completed the survey.
There may also have been a response bias, as it was a
voluntary survey, and those who were in favour of the
implementation of pill testing may have been more eager
to participate.
Readers should bear in mind that sections of the sur-
vey relied heavily on individual’s knowledge of various
illicit substances. Specific substances that were listed
such as methylone or PMA/PMMA could also be con-
sidered a MDMA-type drug. Lack of knowledge of these
substances, and their potential harm or limited aware-
ness regarding what substances individuals were
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consuming may affect the accuracy of responses in these
sections of the survey. This could skew the data for the
drugs that individuals had consumed in the previous 12
months as well as the questions relating to the specific
substances identified in pill testing, and whether the
presence of these would affect their decision to take the
drug. Participants’ perception of when a drug is consid-
ered harmful would also vary by participant. The survey
did not provide a definition of harmful. Another related
limitation was that any substances other than MDMA
were a priori labelled as potentially harmful and thus
could have been considered dangerous by the participant
with limited knowledge.
Another factor that may have altered people’s opin-
ions on pill testing was their knowledge of the pur-
pose and processes involved in the testing. Those
with limited knowledge on pill testing would have to
rely on the explanation on the survey, and in the
short amount of time that they would undertake the
survey they would have to form many opinions about
the process. This could be of concern as those with
previous exposure to the idea of pill testing services
would have had more time to reflect, question and
form their opinions.
In an environment where individuals were consum-
ing alcohol and illicit substances, severely intoxicated
individuals partaking in the study could have altered
the outcomes. Although this was minimised by
recruiting participants in the morning and screening
individuals for physical signs of intoxication (sup-
ported by RSA: Responsible Service of Alcohol train-
ing under the NSW Liquor Act 2007), it is a
limitation that should be considered when interpret-
ing the findings.
It was noted that the open-ended questions in the sur-
vey were poorly answered, resulting in considerable
amounts of missing data. We therefore were not able to
draw any conclusions from the open-ended questions.
Conclusion
A high proportion of live music attendees consume
alcohol and drugs, especially ecstasy. This suggests
that they are a high-risk group that could potentially
benefit from harm minimisation strategies. Both
people who have and who have not used illicit drugs
support the implementation of pill testing services.
People would change their consumption patterns ac-
cording to the results given by pill testing services
and are also in favour of pill testing services com-
bined with harm reduction advice. Increased fre-
quency of MDMA usage is associated with increased
likelihood of taking a pill despite pill testing services
detecting a harmful substance. The findings may be
used to stimulate public debate, and assist drug and
alcohol policy makers in the implementation of harm
minimisation strategies such as combining pill testing
services with harm reduction advice.
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